| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,108 | 20,138 | 24,848 | 24,701 | | Cost of Revenue | 10,254 | 11,860 | 15,215 | 15,339 | | | Gross Profit | 5,854 | 8,278 | 9,633 | 9,362 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,032 | 3,248 | 4,064 | 3,567 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,822 | 5,030 | 5,569 | 5,795 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (81) | 18 | 30 | 83 | | Earnings Before Interest And Taxes | 2,741 | 5,048 | 5,599 | 5,878 | | Interest Expense | 33 | 1 | 1 | 1 | | Income Before Tax | 2,708 | 5,047 | 5,598 | 5,877 | | Income Tax Expense | 1,240 | 1,529 | 2,017 | 2,087 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,468 | 3,518 | 3,581 | 3,790 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,468 | 3,518 | 3,581 | 3,790 | | Preferred Stock And Other Adjustments |
-
|
-
| 557 | (557) | | | Net Income Applicable To Common Shares | $1,468 | $3,518 | $4,138 | $3,233 |
|
0.29% Nasdaq 0.00%
Income Statement
